Treatment Set TS331413 - Treatment Set TS331413

Navigation: NDC > Supplier starting with: A > ANTIGEN LABORATORIES, INC.

Field	Value
NDC Code:	49288-0665
Proprietary Name:	Treatment Set TS331413
Suffix:
Non-Proprietary Name:	Treatment Set TS331413
Dosage Form:	INJECTION, SOLUTION
Method:	INTRADERMAL; SUBCUTANEOUS
Original Marketing Date:	31-10-1986
Category Name:	BLA
Application Number:	BLA102223
Labeler:	ANTIGEN LABORATORIES, INC.
Substance Name:	AMBROSIA ARTEMISIIFOLIA POLLEN; CARYA ALBA POLLEN; CARYA ILLINOINENSIS POLLEN; CYNODON DACTYLON POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; PHLEUM PRATENSE POLLEN; QUERCUS ALBA POLLEN; ULMUS AMERICANA POLLEN
Active Numerator Strength:	10000; .002; .002; 1000; .005; .005; 800; .005; .005
Active Ingredient Unit:	[AU]/mL; g/mL; g/mL; [BAU]/mL; g/mL; g/mL; [BAU]/mL; g/mL; g/mL
Pharm Classes:	Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]
DEA Schedule: